These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 5551351)

  • 21. [Analysis of chemotherapy with 2d line drugs in patients with chronic fibro-cavernous pulmonary tuberculosis].
    Warm S
    Gruzlica; 1971; 39(3):201-7. PubMed ID: 4102332
    [No Abstract]   [Full Text] [Related]  

  • 22. [Early and late results of treatment of patients with tuberculosis shedding mycobacteria with primary resistance to basic antituberculous drugs].
    Dubrawska H; Gryziecka T; Maceluch-Wojtkowa M; Orzechowska W
    Wiad Lek; 1968 Jan; 21(2):77-80. PubMed ID: 5671874
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clinical importance of primary resistance to major drugs in pulmonary tuberculosis patients].
    Balestrino E; Pio A
    Torax; 1967 Jun; 16(2):64-9. PubMed ID: 5614163
    [No Abstract]   [Full Text] [Related]  

  • 24. [Conversion of the sputum--only a relative success measurement in the treatment of tuberculosis. Bacteriological study of 614 resection preparations].
    Winter G; Viereck HJ
    Med Welt; 1972 Sep; 23(38):1294-7. PubMed ID: 5078662
    [No Abstract]   [Full Text] [Related]  

  • 25. [Polychemotherapy of bacteriologically positive pulmonary tuberculosis in patients with the treatment duration of over 10 years].
    Panajotović H; Marsenić B
    Plucne Bolesti Tuberk; 1972; 24(1):30-4. PubMed ID: 5045386
    [No Abstract]   [Full Text] [Related]  

  • 26. [Dynamics of the release of bacilli and the closing of caverns in newly identified tuberculosis patients undergoing different chemotherapeutic regimens].
    Muratov VV; Pashkov IuN; Pospelov VV
    Probl Tuberk; 1981 Dec; (12):30-4. PubMed ID: 6801646
    [No Abstract]   [Full Text] [Related]  

  • 27. [Possibilities of achieving sputum negativity in chronic tuberculous patients in closed antitubercular institutions].
    Mlekodaj S
    Gruzlica; 1968 Oct; 36(10):877-80. PubMed ID: 5710091
    [No Abstract]   [Full Text] [Related]  

  • 28. Factors influencing time to smear conversion in patients with smear-positive pulmonary tuberculosis.
    Wang JY; Lee LN; Yu CJ; Chien YJ; Yang PC;
    Respirology; 2009 Sep; 14(7):1012-9. PubMed ID: 19659516
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparison between a 9-month regimen and 18-month regimen for the initial treatment of pulmonary tuberculosis patients with a positive sputum culture].
    Han JJ
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1984 Aug; 7(4):203-5, 253. PubMed ID: 6543767
    [No Abstract]   [Full Text] [Related]  

  • 30. Primary drug resistance.
    Oka S; Tamagawa S; Ono S
    Sci Rep Res Inst Tohoku Univ Med; 1966 Jun; 13(1):1-4. PubMed ID: 5963578
    [No Abstract]   [Full Text] [Related]  

  • 31. [Which patients are dying of tuberculosis in the 90-s?].
    Vadász I; Popovics Z; Fodor T
    Orv Hetil; 1993 Oct; 134(42):2305-7. PubMed ID: 8233445
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Specific serum antimycobacterial activity test in pulmonary tuberculosis patients].
    Yamagata Y; Konomata T
    Iryo; 1966 May; 20(5):450-5. PubMed ID: 5963052
    [No Abstract]   [Full Text] [Related]  

  • 33. [Reasons for failures in chemotherapy of tuberculosis].
    Langer C
    Beitr Klin Erforsch Tuberk Lungenkr; 1968; 138(1):1-6. PubMed ID: 4977386
    [No Abstract]   [Full Text] [Related]  

  • 34. The short-course treatment of tuberculosis in Spain.
    Guerra Sanz FJ
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1985; 34(2):141-8. PubMed ID: 2999951
    [No Abstract]   [Full Text] [Related]  

  • 35. [Drug resistance of Mycobacteria tuberculosis in patients with new-onset pulmonary tuberculosis].
    Khudushina TA; Voloshina EP; Adamovich NV; Maslakova MG; Terekhova ND
    Probl Tuberk Bolezn Legk; 2005; (12):37-9. PubMed ID: 16496762
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A study on chemotherapy using so-called tertiary drugs for severe cavitary pulmonary tuberculosis failed to respond to chemotherapy by primary and secondary antituberculous drugs].
    Nagata A; Matsumoto M; Yamamoto M; Nakamura H
    Kekkaku; 1966 Jun; 41(6):207-13. PubMed ID: 4290189
    [No Abstract]   [Full Text] [Related]  

  • 37. [Late results of an experimental pilot for short-term tuberculosis chemotherapy in cases that are positive by microscopy].
    Anastasatu C; Bercea O; Corlan E
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1984; 33(4):321-34. PubMed ID: 6097991
    [No Abstract]   [Full Text] [Related]  

  • 38. [Experiences with ambulatory therapy of infectious pulmonary tuberculosis].
    Kropp R; Dissmann E
    Prax Klin Pneumol; 1983 Feb; 37(2):63-6. PubMed ID: 6835925
    [No Abstract]   [Full Text] [Related]  

  • 39. [Fate of patients discharged from the hospital with cavity in the lung after several months of antitubercular chemotherapy].
    Kochnowski G
    Gruzlica; 1967 May; 35(5):435-9. PubMed ID: 6056257
    [No Abstract]   [Full Text] [Related]  

  • 40. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
    Bwire R; Borgdorff MW; Sticht-Groh V; Rieder HL; Kawuma HJ; Bretzel G; Rüsch-Gerdes S
    East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.